Evaluation of three methods using deoxyribonuclease production as a screening test forSerratia marcescens
- 1 May 1971
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 24 (4) , 313-316
- https://doi.org/10.1136/jcp.24.4.313
Abstract
Deoxyribonuclease (DNase) produced by Serratia marcescens is a characteristic feature which is useful in distinguishing this organism from closely related members of the Enterobacteriaceae. In an assessment of three methods of performing the DNase test as a screening procedure for Serratia marcescens, the conclusion was reached that the standard test was most suitable for use in the clinical bacteriology laboratory.Keywords
This publication has 18 references indexed in Scilit:
- Serratia marcescens SepticemiaArchives of Surgery, 1969
- INFECTIONS DUE TO GRAM-NEGATIVE ORGANISMS: AN ANALYSIS OF 860 PATIENTS WITH BACTEREMIA AT THE UNIVERSITY OF MINNESOTA MEDICAL CENTER, 1958–1966Medicine, 1969
- Serratia marcescens EndocarditisArchives of Surgery, 1969
- A Hospital Outbreak of Serratia marcescens Associated with Ultrasonic NebulizersAnnals of Internal Medicine, 1968
- Further use of deoxyribonuclease in a screening test forSerratiaJournal of Clinical Pathology, 1968
- Serratia marcescens SepticemiaArchives of internal medicine (1960), 1968
- Infections and Antibiotic Use among Patients at Boston City Hospital, February, 1967New England Journal of Medicine, 1968
- Fatal transfusion reaction due to Serratia marcescensJournal of Clinical Pathology, 1967
- Serratia Marcescens Infection Complicating Peritoneal DialysisBMJ, 1965
- Hospital infection yesterday and todayJournal of Clinical Pathology, 1961